Jun 29, 2026 07:18 PM
(This post was last modified: Jun 29, 2026 07:38 PM by C C.)
Supreme Court ruling on Roundup points to a confusing difference between the law and science
https://www.statnews.com/2026/06/27/roun...eme-court/
EXCERPTS: When the Supreme Court handed Monsanto a major win in Roundup litigation on Thursday, the headlines sounded like a scientific event: a case about whether Roundup causes cancer. But Monsanto v. Durnell did not settle that question. The court held that federal pesticide law preempts a state failure-to-warn claim when the Environmental Protection Agency has not required a cancer warning on the product label.
That is an important legal ruling. It is not the same thing as a scientific finding that glyphosate is safe or unsafe. The ruling is just the most recent example of a serious problem: Science and law use the same word — causation — while asking different questions.
My own work has moved between clinical care, population-health research, and law, and that border is where this confusion becomes most visible. In epidemiology, causation is usually a population-level inference. Researchers ask whether an exposure reliably changes disease risk across groups of people. That requires replication, statistical association, dose-response evidence, biological plausibility, and efforts to rule out confounding. Even then, conclusions remain probabilistic. A risk factor can increase disease likelihood without proving why one person became ill.
[...] Talc litigation shows the same problem in another form. Johnson & Johnson and other defendants have faced claims that talc-based products contributed to ovarian cancer or mesothelioma. Some claims focus on talc itself. Others focus on alleged asbestos contamination, a different issue because asbestos is a well-established carcinogen. In 2024, IARC classified talc as probably carcinogenic to humans, based on limited evidence in humans, sufficient evidence in experimental animals, and strong mechanistic evidence.
That classification matters. But it still does not mean every cancer occurring after talc use was caused by talc.
The scientific question is specific: Does talc, asbestos-contaminated talc, or perineal talc use reliably increase cancer risk across populations, under what exposure conditions, and with what level of confidence? The courtroom question is different: Would this plaintiff’s injury have occurred but for the product exposure, and was that causal link legally sufficient to assign responsibility?
Talc litigation also shows why juries do not evaluate causation in a sterile scientific vacuum. Plaintiffs may argue not only epidemiology, but corporate knowledge, internal documents, inadequate warnings, disputed testing practices, and alleged concealment. If jurors believe a company acted deceptively, they may interpret ambiguous scientific evidence more aggressively.
The problem is intensified because people are uncomfortable with randomness. Cancer feels too consequential to attribute to background risk, chance, or multifactorial vulnerability, so jurors and the public naturally search for a concrete cause. These same dynamics are now playing out in litigation over social media and youth mental health.
[...] Science is designed to estimate risk, test hypotheses, identify patterns, and reduce the likelihood of false causal inference. Law is designed to resolve disputes, assign responsibility, compensate injury, deter misconduct, and impose duties. Those functions are related, but not the same.
This distinction matters for public trust. If people believe a jury verdict proves scientific consensus, later scientific caution may look corrupt. If people believe regulatory caution invalidates every legal claim, courts may look irrational. If people believe a settlement proves causation, the absence of admitted liability may look like evasion.
So what should be done? First, courts and lawyers should be more explicit about which causal question is being answered: general causation, specific causation, regulatory risk, failure to warn, product design, foreseeability, or legal preemption.
Second, expert testimony and public reporting should keep those categories separate. A hazard classification is not the same thing as proof that a product caused one plaintiff’s injury. A settlement is not the same thing as admitted causation. A regulatory decision is not the same thing as a jury verdict. A Supreme Court preemption ruling is not the same thing as a scientific exoneration.
Journalists have a role here, too. Coverage of cases involving Roundup, social media, talc, and other tricky topics should tell readers not only who won, but what question the court actually answered. Monsanto v. Durnell was a landmark ruling about federal pesticide labeling and state tort law. It was not a final scientific verdict on glyphosate.
Public trust will keep eroding if every legal outcome is treated as though it were a scientific finding. A courtroom can assign responsibility without settling science. Science can remain cautious without denying harm. And courts can limit liability without proving that a product is harmless... (MORE - missing details)
https://www.statnews.com/2026/06/27/roun...eme-court/
EXCERPTS: When the Supreme Court handed Monsanto a major win in Roundup litigation on Thursday, the headlines sounded like a scientific event: a case about whether Roundup causes cancer. But Monsanto v. Durnell did not settle that question. The court held that federal pesticide law preempts a state failure-to-warn claim when the Environmental Protection Agency has not required a cancer warning on the product label.
That is an important legal ruling. It is not the same thing as a scientific finding that glyphosate is safe or unsafe. The ruling is just the most recent example of a serious problem: Science and law use the same word — causation — while asking different questions.
My own work has moved between clinical care, population-health research, and law, and that border is where this confusion becomes most visible. In epidemiology, causation is usually a population-level inference. Researchers ask whether an exposure reliably changes disease risk across groups of people. That requires replication, statistical association, dose-response evidence, biological plausibility, and efforts to rule out confounding. Even then, conclusions remain probabilistic. A risk factor can increase disease likelihood without proving why one person became ill.
[...] Talc litigation shows the same problem in another form. Johnson & Johnson and other defendants have faced claims that talc-based products contributed to ovarian cancer or mesothelioma. Some claims focus on talc itself. Others focus on alleged asbestos contamination, a different issue because asbestos is a well-established carcinogen. In 2024, IARC classified talc as probably carcinogenic to humans, based on limited evidence in humans, sufficient evidence in experimental animals, and strong mechanistic evidence.
That classification matters. But it still does not mean every cancer occurring after talc use was caused by talc.
The scientific question is specific: Does talc, asbestos-contaminated talc, or perineal talc use reliably increase cancer risk across populations, under what exposure conditions, and with what level of confidence? The courtroom question is different: Would this plaintiff’s injury have occurred but for the product exposure, and was that causal link legally sufficient to assign responsibility?
Talc litigation also shows why juries do not evaluate causation in a sterile scientific vacuum. Plaintiffs may argue not only epidemiology, but corporate knowledge, internal documents, inadequate warnings, disputed testing practices, and alleged concealment. If jurors believe a company acted deceptively, they may interpret ambiguous scientific evidence more aggressively.
The problem is intensified because people are uncomfortable with randomness. Cancer feels too consequential to attribute to background risk, chance, or multifactorial vulnerability, so jurors and the public naturally search for a concrete cause. These same dynamics are now playing out in litigation over social media and youth mental health.
[...] Science is designed to estimate risk, test hypotheses, identify patterns, and reduce the likelihood of false causal inference. Law is designed to resolve disputes, assign responsibility, compensate injury, deter misconduct, and impose duties. Those functions are related, but not the same.
This distinction matters for public trust. If people believe a jury verdict proves scientific consensus, later scientific caution may look corrupt. If people believe regulatory caution invalidates every legal claim, courts may look irrational. If people believe a settlement proves causation, the absence of admitted liability may look like evasion.
So what should be done? First, courts and lawyers should be more explicit about which causal question is being answered: general causation, specific causation, regulatory risk, failure to warn, product design, foreseeability, or legal preemption.
Second, expert testimony and public reporting should keep those categories separate. A hazard classification is not the same thing as proof that a product caused one plaintiff’s injury. A settlement is not the same thing as admitted causation. A regulatory decision is not the same thing as a jury verdict. A Supreme Court preemption ruling is not the same thing as a scientific exoneration.
Journalists have a role here, too. Coverage of cases involving Roundup, social media, talc, and other tricky topics should tell readers not only who won, but what question the court actually answered. Monsanto v. Durnell was a landmark ruling about federal pesticide labeling and state tort law. It was not a final scientific verdict on glyphosate.
Public trust will keep eroding if every legal outcome is treated as though it were a scientific finding. A courtroom can assign responsibility without settling science. Science can remain cautious without denying harm. And courts can limit liability without proving that a product is harmless... (MORE - missing details)
